ZOFENIL 30 mg film-coated tablet Ireland - English - HPRA (Health Products Regulatory Authority)

zofenil 30 mg film-coated tablet

menarini international operations luxembourg s.a. - zofenopril calcium - film-coated tablet - 30 milligram(s) - ace inhibitors, plain; zofenopril

ZOFENIL 7.5 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

zofenil 7.5 mg film-coated tablets

menarini international operations luxembourg s.a. - zofenopril calcium - film-coated tablet - 7.5 milligram(s) - ace inhibitors, plain; zofenopril

Odrik 0.5mg Hard Capsules Ireland - English - HPRA (Health Products Regulatory Authority)

odrik 0.5mg hard capsules

mylan ire healthcare limited - trandolapril - capsule, hard - 0.5 milligram(s) - ace inhibitors, plain; trandolapril - ace inhibitors, plain - all grades of essential hypertension; improves survival following myocardial infarction in patients with left ventricular dysfunction (ejection fraction  35 percent), with or without symptoms of heart failure and/or with or without residual ischaemia; reduces significantly the overall mortality, especially from cardiovascular mortality. it significantly decreases the risk of sudden death and the occurrence of severe or resistant heart failure, and tends to decrease the incidence of fatal and non-fatal reinfarctions.

Odrik 1mg Hard Capsules Ireland - English - HPRA (Health Products Regulatory Authority)

odrik 1mg hard capsules

mylan ire healthcare limited - trandolapril - capsule, hard - 1.0 milligram(s) - ace inhibitors, plain; trandolapril - ace inhibitors, plain - all grades of essential hypertension; improves survival following myocardial infarction in patients with left ventricular dysfunction (ejection fraction  35 percent), with or without symptoms of heart failure and/or with or without residual ischaemia; reduces significantly the overall mortality, especially from cardiovascular mortality. it significantly decreases the risk of sudden death and the occurrence of severe or resistant heart failure, and tends to decrease the incidence of fatal and non-fatal reinfarctions